betamethasone has been researched along with timolol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Akagi, Y; Itoi, M; Kodama, Y; Sasamoto, K | 1 |
| Kheradvar, A; Rad, AS | 1 |
| Greiner, B; Laengle, UW; Markstein, R; Roman, D; Schneider, V | 1 |
| Hajizadeh, M; Idani, E; Panahi-Bazaz, M; Saki, A; Sharifipour, F | 1 |
| Huang, H; Li, W; Xu, P; Yu, Q; Zhang, W | 1 |
| Lan, SJ; Liu, M; Liu, SS; Rong, L; Yang, TY; Zhang, JY | 1 |
1 trial(s) available for betamethasone and timolol
| Article | Year |
|---|---|
Oxygen therapy for corneal edema after cataract surgery.
Topics: Adrenergic beta-Antagonists; Aged; Betamethasone; Corneal Edema; Corneal Pachymetry; Endothelium, Corneal; Female; Glucocorticoids; Humans; Intraocular Pressure; Isotonic Solutions; Male; Middle Aged; Oxygen; Phacoemulsification; Sodium Chloride; Timolol; Visual Acuity | 2015 |
15 other study(ies) available for betamethasone and timolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Corneal endothelial changes caused by ophthalmic drugs.
Topics: Animals; Betamethasone; Conjunctiva; Cornea; Endothelium; Epinephrine; Gentamicins; Injections; Ophthalmic Solutions; Rabbits; Timolol | 1984 |
Juvenile xanthogranuloma: concurrent involvement of skin and eye.
Topics: Acetazolamide; Atropine; Betamethasone; Drug Therapy, Combination; Eye Diseases; Humans; Infant; Intraocular Pressure; Male; Skin Diseases; Timolol; Xanthogranuloma, Juvenile | 2001 |
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Aqueous Humor; Betamethasone; Dopamine Agents; Eye Proteins; Glaucoma; Injections, Subcutaneous; Lipopolysaccharides; Quinolines; Rats; Rats, Inbred Lew; Timolol; Tumor Necrosis Factor-alpha; Uveitis | 2005 |
A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas.
Topics: Administration, Topical; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Ointments; Timolol | 2018 |
Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Skin Neoplasms; Timolol; Treatment Outcome | 2021 |